Complementary and alternative medicines in ankylosing spondylitis: A cross-sectional study

Clinical Rheumatology

Volumn 28, Issue 2, 2009, Pages 213-217

  Chatfield, Simon M ^a   Dharmage, Shyamali C ^b   Boers, Anthony ^c   Martin, Belinda J ^d   Buchanan, Russell R C ^d   Maksymowych, Walter P ^e   Schachna, Lionel ^d  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d AUSTIN HEALTH   (Australia)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Ankylosing spondylitis; Complementary and alternative medicines; Diet; Prevalence

Indexed keywords

COPPER COMPLEX; FISH OIL; GLUCOSAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VITAMIN;

ACUPUNCTURE; ADULT; ALTERNATIVE MEDICINE; ANKYLOSING SPONDYLITIS; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET THERAPY; DISEASE ACTIVITY; EDUCATIONAL STATUS; FEMALE; HEALTH CARE COST; HOMEOPATHY; HUMAN; MAGNETOTHERAPY; MAJOR CLINICAL STUDY; MALE; MASSAGE; PREVALENCE; PRIORITY JOURNAL; TEA; VITAMIN SUPPLEMENTATION;

ACUPUNCTURE; ADULT; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; DIET THERAPY; FEMALE; HOMEOPATHY; HUMANS; MALE; MASSAGE; MIDDLE AGED; PREVALENCE; REFERRAL AND CONSULTATION; SOCIAL CLASS; SPONDYLITIS, ANKYLOSING;

EID: 58149188039     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-008-1029-3     Document Type: Article

References (24)

1. Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379-1390
2. van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J et al (2006) Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 54:2136-2146
3. Jois RN, Gaffney K, Keat A (2007) Anti-tumour necrosis factor therapy for ankylosing spondylitis-unresolved issues. Rheumatology 46:899-901
4. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:2275-2285
5. Rao JK, Mihaliak K, Kroenke K, Bradley J, Tierney WM, Weinberger M (1999) Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 131:409-416
6. Cronan TA, Kaplan RM, Posner L, Blumberg E, Kozin F (1989) Prevalence of the use of unconventional remedies for arthritis in a metropolitan community. Arthritis Rheum 32:1604-1607
7. Buchbinder R, Gingold M, Hall S, Cohen M (2002) Non-prescription complementary treatments used by rheumatoid arthritis patients attending a community-based rheumatology practice. Intern Med J 32:208-214
8. Zochling J, March L, Lapsley H, Cross M, Tribe K, Brooks P (2004) Use of complementary medicines for osteoarthritis - a prospective study. Ann Rheum Dis 63:549-554
9. Herman CJ, Allen P, Hunt WC, Prasad A, Brady TJ (2004) Use of complementary therapies among primary care clinic patients with arthritis. Prev Chronic Dis 1:A12
10. Cronan TA, Kaplan RM, Kozin F (1993) Factors affecting unprescribed remedy use among people with self-reported arthritis. Arthritis Care Res 6:149-155
11. Moore AD, Petri MA, Manzi S, Isenberg DA, Gordon C, Senecal JL et al (2000) The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study Group. Arthritis Rheum 43:1410-1418
12. Fautrel B, Adam V, St-Pierre Y, Joseph L, Clarke AE, Penrod JR (2002) Use of complementary and alternative therapies by patients self-reporting arthritis or rheumatism: Results from a nationwide canadian survey. J Rheumatol 29:2435-2441
13. Haugen M, Kjeldsen-Kragh J, Nordvag BY, Forre O (1991) Diet and disease symptoms in rheumatic diseases - results of a questionnaire based survey. Clin Rheumatol 10:401-407
14. Ramos-Remus C, Watters CA, Dyke L, Suarez-Almazor ME, Russell AS (1999) Assessment of health locus of control in the use of nonconventional remedies by patients with rheumatic diseases. J Rheumatol 26:2468-2474
15. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361-368
16. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286-2291
17. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281-2285
18. Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ et al (2003) Development of the ASQoL: A quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62:20-26
19. Jones SD, Steiner A, Garrett SL, Calin A (1996) The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 35:66-71
20. Australian bureau of statistics, Commonwealth of Australia. Socioeconomic indexes for areas (SEIFA) Volume 1.1. Australian bureau of statistics: Canberra, Australia, 2001
21. Feldman DE, Duffy C, De Civita M, Malleson P, Philibert L, Gibbon M et al (2004) Factors associated with the use of complementary and alternative medicines in juvenile idiopathic arthritis. Arthritis Rheum 51:527-532
22. MacLennan AH, Wilson DH, Taylor AW (1996) Prevalence and cost of alternative medicine in Australia. Lancet 347:569-573
23. Sundstrom B, Stalnacke K, Hagfors L, Johansson G (2006) Supplementation of omega-3 fatty acids in patients with ankylosing spondylitis. Scand J Rheumatol 35:359-362
24. Vecchio PC (1994) Attitudes to alternative medicine by rheumatology outpatient attenders. J Rheumatol 21:145-147